Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06627504

Type 1 Diabetes REst for Metabolic Health

Mechanisms Underlying the Relationship Between Sleep and Circadian Health and Cardiometabolic Risk in Adolescents With Type 1 Diabetes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
14 Years – 19 Years
Healthy volunteers
Not accepted

Summary

Research has shown a link between poor sleep health and late circadian timing with cardiometabolic health in adolescents with type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in T1D, which begins as early as adolescence, and current therapies are limited. Therefore, this study plans to investigate whether cardiometabolic health can be improved with increased sleep duration and advanced circadian timing in adolescents with T1D with habitually insufficient sleep. To answer this question, investigators will study adolescents with T1D who get \<7h sleep on school nights and measure changes in insulin sensitivity, glycemic control, and vascular function after one month of a sleep and circadian intervention (1+ hour longer time in bed each night plus evening melatonin and morning light therapy) compared to one month of typical sleep (usual school schedule).

Conditions

Interventions

TypeNameDescription
BEHAVIORALSleep Health and Circadian Timing InterventionParticipants will be prescribed a sleep schedule that allows them to obtain at least 1h more time in bed compared to their typical school week schedule. In addition, participants will be provided with pharmaceutical-grade exogenous melatonin and instructed to take 500mcg 2 hours before their scheduled bedtime. They will also be asked reduce evening light exposure starting 2 hours before bedtime by limiting household lights and dimming electronics. In the mornings, participants will be exposed to bright light for 30 minutes after waking by wearing provided ReTimer light therapy glasses.

Timeline

Start date
2025-08-12
Primary completion
2029-05-31
Completion
2029-08-31
First posted
2024-10-04
Last updated
2025-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06627504. Inclusion in this directory is not an endorsement.